This collaboration marks an important step for RetinaLyze as Bloxx Digital Innovation becomes an official distributor of RetinaLyze products in the Spanish market.
The partnership combines RetinaLyze’s cutting-edge AI technology for eye screenings with Bloss Group’s established presence in the Spanish ophthalmology sector. By joining forces, the two companies aim to improve access to advanced eye care solutions and enhance the early detection of eye diseases throughout the region.
RetinaLyze has revolutionized the eye care industry with its state-of-the-art software, which has already performed over six million screenings across Europe, identifying more than 70,000 potential eye disease cases. The software is widely used in hospitals and eye clinics, providing fast and accurate screenings that help healthcare professionals detect conditions such as diabetic retinopathy, age-related macular degeneration, and glaucoma at an early stage.
Bloss Group is a leading supplier of innovative ophthalmic equipment and surgical materials in Spain. The company offers a wide range of ophthalmic devices and instruments from renowned manufacturers such as Heidelberg Engineering, Haag-Streit and Mani, to name a few. With a strong commitment to quality, innovation and customer service, Bloss Group is a trusted partner in the Spanish ophthalmic market.
Bloxx Digital Innovation is Bloss Group’s new strategic software and AI company, born with the purpose of providing the country’s eye care professionals with the most advanced and cutting-edge digital innovations.
The distribution agreement between RetinaLyze and Bloxx Digital Innovation leverages the strengths of both companies to deliver innovative eye care solutions to healthcare providers in Spain. This partnership will facilitate the integration of RetinaLyze’s AI technology into existing ophthalmology practices, providing professionals with powerful tools to enhance patient care.
“We are thrilled to collaborate with Bloxx Digital Innovation to expand access to RetinaLyze’s AI-driven screening technology in Spain,” said Teddy Birch Petersen, CEO of RetinaLyze. “This partnership will empower eye care professionals with innovative tools to detect eye diseases earlier and enhance patient outcomes.”
“This strategic alliance with RetinaLyze is aligned with our commitment of innovation and continuous improvement in the eye care market. – said Daniela Losada, CEO at Bloss Group – “It will allow us to offer cutting-edge solutions that will transform the way eye care professionals detect and treat eye disease, benefiting thousands of patients in the region.” For more information about RetinaLyze and its products, please visit https://retinalyze.com. To learn more about Bloss Group and its offerings, visit https://blossgroup.com/.
Teddy Birch Petersen
CEO
RetinaLyze System A/S
tbp@retinalyze.com
Daniela Losada Bloss
CEO
Bloss Group
dlosada@blossgroup.com
Alba Baños
Marketing Manager
Bloss Group
abanos@blossgroup.com
RetinaLyze System A/S is a Denmark-based software company that provides artificial intelligence and telemedicine solutions for the optometry and healthcare industry. Its innovative software platform is designed to assist healthcare professionals in the early detection of eye diseases, enhancing patient outcomes through timely intervention.
Bloss Group is a leading supplier of innovative medical technology in ophthalmology in Spain. specializing in diagnostic and treatment equipment, it is committed to innovation, high quality products and customer service. With the launch of their new division, Bloxx Digital Innovation, they aim to provide the best software and AI solutions to drive the ophthalmology market into a new era.
